The Views of 109 French Patient Groups on the Corporate Reputation of Pharma in 2021-2022: Amgen, Mylan, Eli Lilly, MSD, and Boehringer Ingelheim Witnessed the Biggest Rise in Rankings
January 12, 2023 06:18 ET
|
Research and Markets
Dublin, Jan. 12, 2023 (GLOBE NEWSWIRE) -- The "The Corporate Reputation of Pharma in 2021- The Patient Perspective - France Edition - The Views of 109 French Patient Groups" report has been added to...
Corporate Reputation of Pharma Companies in Spain, 2020 vs 2021: ViiV Healthcare Ranked 1st, Janssen Ranked 2nd, Gilead Sciences Ranked 3rd
January 09, 2023 08:48 ET
|
Research and Markets
Dublin, Jan. 09, 2023 (GLOBE NEWSWIRE) -- The "The Corporate Reputation of Pharma in 2021 - The Patient Perspective - Spain Edition: The Views of 154 Spanish Patient Groups" report has been added to...
Autoimmune Patient Perspective on the Corporate Reputation of Pharma Companies, 2021-2022: Focus on Innovation and Treatments, COVID-19, & Pricing and Access to Medicines
January 09, 2023 08:28 ET
|
Research and Markets
Dublin, Jan. 09, 2023 (GLOBE NEWSWIRE) -- The "The Corporate Reputation of Pharma in 2021- The Patient Perspective - Autoimmune Edition - The Views of 293 Patient Groups (138 of these respondent...
Patient Perspective of the Corporate Reputation of Pharma in 2021-2022: Focus on Chiesi Farmaceutici, AbbVie, Bayer, Eli Lilly, GSK, Merck, Mylan, Novartis, Pfizer, Roche, Sanofi, Teva Among Others
January 09, 2023 08:23 ET
|
Research and Markets
Dublin, Jan. 09, 2023 (GLOBE NEWSWIRE) -- The "The Corporate Reputation of Pharma in 2021 - The Patient Perspective - Respiratory Edition - The Views of 121 Respiratory Conditions Patient Groups"...
The Corporate Reputation of Pharma Companies in Canada, 2021-2022: AbbVie, Roche, BMS, Sanofi, Pfizer, Merck, Bayer and Amgen Made the Biggest Rises
January 09, 2023 08:18 ET
|
Research and Markets
Dublin, Jan. 09, 2023 (GLOBE NEWSWIRE) -- The "The Corporate Reputation of Pharma in 2021 - The Patient Perspective - Canada Edition - The Views of 124 Canadian Patient Groups" report has been added...
Corporate Reputation of Pharma in United States, 2021-2022: The Patient Perspective of 40+ Companies 2021 v. 2020
January 09, 2023 08:13 ET
|
Research and Markets
Dublin, Jan. 09, 2023 (GLOBE NEWSWIRE) -- The "The Corporate Reputation of Pharma in 2021 - The Patient Perspective - USA Edition - The Views of 240 USA Patient Groups" report has been added to ...
Corporate Reputation of Pharma Companies in 2021-2022: The Patient Perspective of 520 Cancer Patient Groups - Pfizer Ranked 1st, Roche/Genentech Ranked 2nd and Novartis was 3rd
January 05, 2023 05:53 ET
|
Research and Markets
Dublin, Jan. 05, 2023 (GLOBE NEWSWIRE) -- The "The Corporate Reputation of Pharma in 2021 - The Patient Perspective - Cancer Edition - The Views of 520 Cancer Patient Groups" report has been added...
Corporate Reputation of the Pharma Companies 2021-2022 Based on 168 HIV/AIDS Patient Groups: AbbVie, BMS, Gilead Sciences, GSK, Janssen, Merck, Mylan, Roche/Genentech, Sandoz, Sanofi, Teva, ViiV
December 13, 2022 05:28 ET
|
Research and Markets
Dublin, Dec. 13, 2022 (GLOBE NEWSWIRE) -- The "The Corporate Reputation of Pharma in 2021 - The Patient Perspective - HIV/AIDS Edition -The Views of 168 HIV/AIDS Patient Groups" report has been...
The Corporate Reputation of Pharma in 2021-2022: The Views of 303 Rare-Disease Patient Groups on 32 Pharma Companies
December 09, 2022 07:18 ET
|
Research and Markets
Dublin, Dec. 09, 2022 (GLOBE NEWSWIRE) -- The "The Corporate Reputation of Pharma in 2021 - the Patient Perspective - Rare Disease Edition - The Views of 303 Rare-Disease Patient Groups" report has...
UK Patient's Perspective on the Corporate Reputation of Pharma, 2021-2022: The Views of 111 Patients Groups Two Years into COVID-19
December 09, 2022 07:13 ET
|
Research and Markets
Dublin, Dec. 09, 2022 (GLOBE NEWSWIRE) -- The "The Corporate Reputation of Pharma in 2021- The Patient Perspective - UK Edition - The Views of 111 Patient Groups" report has been added to ...